* Applied Molecular Transport Inc. AMTI.OQ AMTI.O is
expected
to show no change in quarterly revenue when it reports
results on November 8 (estimated).
*
* Refinitiv's mean analyst estimate for Applied Molecular
Transport Inc. is for a loss of 65 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Applied
Molecular
Transport Inc. is $13, above its last closing price of $0.87.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 -0.85 -0.78 -0.93 Missed -19.7
Mar. 31 2022 -0.74 -0.75 -1.10 Missed -46.2
Dec. 31 2021 -0.66 -0.66 -0.78 Missed -17.6
Sep. 30 2021 -0.61 -0.62 -0.68 Missed -9.7
Jun. -0.59 -0.60 -0.62 Missed -3.3
30 2021
Mar. 31 2021 -0.75 -0.75 -0.58 Beat 22.7
Dec. 31 2020 -0.51 -0.47 -0.38 Beat 20
Sep. 30 2020 -0.41 -0.41 -0.48 Missed -17.1
This summary was machine generated November 4 at 11:01 GMT. All
figures in US dollars unless otherwise stated